|
已选(0)清除
条数/页： 排序方式：
|
| A retrospective analysis to explore the value of gemcitabine combined with cisplatin as adjuvant chemotherapy of NSCLC 会议论文
ANNALS OF ONCOLOGY, 2017-04-01
作者: Ma, D.; Wang, J.; Hao, X.
  收藏 | 浏览/下载：2/0 | 提交时间：2020/01/04 |
| Phase II clinical trial of first-line combination of radiation followed by gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy for early-stage extranodal natural killer/T-cell lymphoma with unfavorable prognostic factors: The GREEN study 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:
收藏 | 浏览/下载：10/0 | 提交时间：2020/01/04 |
| Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文
CANCER RESEARCH, 2015-05-01
作者:
收藏 | 浏览/下载：3/0 | 提交时间：2020/01/04 |
| Gemcitabine-based regimens without high-dose therapy consolidation generated prolonged disease control in refractory or relapsed Hodgkin lymphoma: a single institutional experience 会议论文
EUROPEAN JOURNAL OF CANCER, 2015-09-01
作者:
收藏 | 浏览/下载：1/0 | 提交时间：2020/01/13 |
| Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type 会议论文
BLOOD, 2014-12-06
作者:
收藏 | 浏览/下载：3/0 | 提交时间：2020/01/13 |
| A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20
作者:
收藏 | 浏览/下载：1/0 | 提交时间：2020/01/13 |
